Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.

The Journal of clinical investigation ·Vol. 41 ·1962-04-00 ·Pages 917-34

ALKJAERSIG N, FLETCHER AP, SHERRY S

Abstract

暂无摘要

Keywords

FIBRIN FIBRINOGEN FIBRINOLYSIS HEMORRHAGIC DIATHESIS/etiology

MeSH Terms

Blood Coagulation Disorders Fibrin Fibrinogen Fibrinolysis Hemorrhagic Disorders/etiology Humans Plasma Polymerization Thrombolytic Therapy

Chemicals

Fibrin Fibrinogen

Authors & Affiliations

3 authors, click to expand affiliations / ORCID

ALKJAERSIG N

FLETCHER A P

SHERRY S

References (17)

17 references, click to expand

Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.
J Clin Invest. 1962 Apr;41:896-916 PMID: 13893560
Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy.
J Clin Invest. 1962 Apr;41:935-48 PMID: 13864646
The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.
J Clin Invest. 1959 Sep;38:1627-43 PMID: 14407413
Anticoagulant effect of incubated fibrinogen.
Can J Biochem Physiol. 1958 Mar;36(3):249-59 PMID: 13511230
[The products of degradation of human fibrinogen by plasmin. I. Separation and physicochemical properties].
Ann Inst Pasteur (Paris). 1961 Mar;100:377-89 PMID: 13729934
xi-Aminocaproic acid: an inhibitor of plasminogen activation.
J Biol Chem. 1959 Apr;234(4):832-7 PMID: 13654273
Effects of intravenous injections of the anticoagulant fraction of incubated fibrinogen on blood coagulation.
Can J Biochem Physiol. 1960 Aug;38:909-18 PMID: 13839325
Studies on paracoagulation. Role of antithrombin VI.
Thromb Diath Haemorrh. 1960 Dec 15;5:285-95 PMID: 13753061
Nature of the thrombin-inhibiting effect of incubated fibrinogen.
Am J Physiol. 1959 Sep;197:575-9 PMID: 13839326
The maintenance of a sustained thrombolytic state in man. I. Induction and effects.
J Clin Invest. 1959 Jul;38(7):1096-110 PMID: 13664785
Anticoagulant action of TAMe and AFIF.
Am J Physiol. 1961 Apr;200:771-4 PMID: 13778034
The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders.
J Clin Invest. 1959 Jul;38(7):1111-9 PMID: 13664786
[The degradation products of human fibrinogen by plasmin. II. Immunological study: existence of native anti-fibrinogen antibodies possessing different specificities].
Ann Inst Pasteur (Paris). 1961 Apr;100:490-508 PMID: 13729933
[A new anticoagulant derived from fibrinogen].
Rev Hematol. 1958 Jul-Sep;13(3):320-8 PMID: 13591884
The mechanism of clot dissolution by plasmin.
J Clin Invest. 1959 Jul;38(7):1086-95 PMID: 13664784
Fibrinolysis and fibrinolytic activity in man.
Physiol Rev. 1959 Apr;39(2):343-82 PMID: 13645238
[Appearance of an inhibitor of thromboplastin formation during proteolysis of fibrinogen].
Rev Hematol. 1959 Apr-Jun;14(2):118-28 PMID: 13675583

Article Info

Journal

The Journal of clinical investigation

Abbr.

J Clin Invest

ISSN

0021-9738

DOI

10.1172/JCI104547

Published

1962-04-00

Pages

917-34

Language

English

Region

United States

NLM ID

7802877

PMCID

PMC290992

Subset

External Links

PubMed source DOI: 10.1172/JCI104547 PMC Full Text View journal details

Analysis Services

Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.

Contact

WeChat Official Account